Strides gets USFDA approval for Flucytosine capsules
Strides Pharma Science Limited (Strides) on Monday announced that its step-down wholly-owned subsidiary, Strides Pharma Global Pte. Limited, Singapo20-04-2020
20-04-2020
Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Strides receives USFDA approval for Flucytosine Capsules20-04-2020
Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Strides provides updates as USFDA requests all manufacturers to withdraw Ranitidine products from the US Market02-04-2020
Strides Pharma receives EIR for Bengaluru facility from USFDA
Strides Pharma Science Ltd has received Establishment Inspection Report (EIR) for the inspection conducted by the US Food and Drug Administration (US30-03-2020
Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Strides announces successful completion of US FDA inspection conducted in January 2020 at flagship facility in Bangalore30-03-2020
Strides Pharma share price gains 8% on EIR from USFDA
The share touched its 52-week high Rs 547.35 and 52-week low Rs 271.00 on 14 February, 2020 and 20 March, 2020, respectively.26-03-2020
Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
EIR from USFDA on continued GMP status for the flagship facility in Bangalore26-03-2020
Stock query: Strides Pharma in a consolidation phase
A decisive fall below 340 can test the long-term support at 30015-03-2020
Strides Pharma Science Ltd - 532531 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding request received for issue of duplicate share certificate under Regulation 39 (3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 - T R SUBRAMANIAN13-03-2020
USFDA nod may boost Strides Pharma
Shares of Strides Pharma Science may attract buying interest, as its wholly-owned subsidiary Strides Pharma Global Pte Ltd, Singapore, has received U04-03-2020